Medable’s France CNIL Regulatory Breakthrough: Pioneering Global Clinical Trials
Medable has achieved a significant milestone by securing regulatory approval from France’s CNIL, enhancing its global clinical trial capabilities....
Revolutionizing Clinical Trials with AI and Decentralization
In the evolving world of clinical trials, AI and decentralization are key drivers of change. Iddo Peleg, CEO of...
Transforming Clinical Trials with AI: Insights from the Frontline
In the rapidly evolving landscape of clinical trials, technology is a game-changer. Dr. Michelle Papka, Ph.D., Founder and President...
Citeline’s Strategic Vision: Bridging Clinical Trials and Real-World Healthcare
In this discussion with Claire Riches, a veteran in clinical development, we explore Citeline’s strategic initiatives. As a leader...
New Obesity Treatment Mechanisms: Dr. Bolz on Aphaia Pharma’s Innovative Approach
In this discussion with Steffen-Sebastian Bolz, MD, PhD, we explore Aphaia’s groundbreaking work in obesity treatment. With his dual...
Revolutionizing NSCLC Treatment: Insights from ImmunityBio’s CMO
In this discussion with Bobby Reddy, Chief Medical Officer of ImmunityBio, we delve into the innovative immunotherapy strategies targeting...
Pelareorep: A Game-Changer in Oncolytic Virus Therapy
In this conversation, we engage with Dr. Thomas Heineman, Chief Medical Officer of Oncolytics Biotech, to explore the innovative...
Transforming Clinical Trials: Medable’s Approach to Diversity and Inclusion
In this interview, we explore clinical trial technology’s impact on diversity and inclusion. Ali Holland from Medable shares insights...
Transforming Oncology with Real World Data: Insights from COTA’s Miruna Sasu
In this conversation with Miruna Sasu, President and CEO of COTA Healthcare, we explore the transformative power of real...
How AI is Minimizing Clinical Trial Protocol Amendments
In this interview, we sit down with Catherine (Cat) Hall, Head of GXP Quality at Egnyte, to discuss how...